Amanote Research
Register
Sign In
Tumor Necrosis Factor Alpha in Inflammatory Bowel Disease.
Gut
- United Kingdom
doi 10.1136/gut.35.5.715
Full Text
Open PDF
Abstract
Available in
full text
Categories
Gastroenterology
Date
May 1, 1994
Authors
I C Talbot
Publisher
BMJ
Related search
Prevalence and Pathogenesis of Anemia in Inflammatory Bowel Disease. Influence of Anti-Tumor Necrosis Factor- Treatment
Haematologica
Hematology
Serious Adverse Events Associated With Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in a Real-Life Setting
Paediatric Drugs
Child Health
Pediatrics
Perinatology
Pharmacology
Spontaneous Inflammatory Demyelinating Disease in Transgenic Mice Showing Central Nervous System-Specific Expression of Tumor Necrosis Factor Alpha.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Serological Markers in Diagnosis of Pediatric Inflammatory Bowel Disease and as Predictors for Early Tumor Necrosis Factor Blocker Therapy
Scandinavian Journal of Gastroenterology
Gastroenterology
Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
N-Acetylcysteine Attenuates Tumor Necrosis Factor Alpha Levels in Autoimmune Inner Ear Disease Patients
Immunologic Research
Immunology
Tumor Necrosis Factor Alpha Mediates Neuromuscular Synapse Elimination
Cell Discovery
Biochemistry
Genetics
Cell Biology
Molecular Biology
Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis
Therapeutics and Clinical Risk Management
Review Article: The Effects of Antitumour Necrosis Factor-Α on Bone Metabolism in Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
